Publications by authors named "Tim Muilwijk"

Claim this Profile
P
Prototol for the Prospective Sample Collection for Cancer of Bladder (ProCaB) Trial by the Cancer of the Bladder Leuven (CaBLe) Consortium.
Murat Akand, Tim Muilwijk, Ben Van Cleynenbreugel, Thomas Gevaert, Steven Joniau

Eur Urol Open Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered studies.
Murat Akand, Tatjana Jatsenko, Tim Muilwijk, Thomas Gevaert, Steven Joniau

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study.
Daimantas Milonas, Alexander Giesen, Tim Muilwijk, Charlotte Soenens, Gaëtan Devos

Eur Urol Open Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non-muscle-invasive Bladder Cancer Progression.
Tim Muilwijk, Loïc Baekelandt, Murat Akand, Sofie Daelemans, Koen Marien

Eur Urol Open Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial.
Christine G J I van Straten, Christien Caris, Marc-Oliver Grimm, Marc Colombel, Tim Muilwijk

Eur Urol Open Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry.
Tim Muilwijk, Murat Akand, Yannic Raskin, Cedric Jorissen, Kathy Vander Eeckt

Eur Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological features characterising indeterminate testes masses: a systematic review and meta-analysis.
Michael Ager, Sarah Donegan, Luca Boeri, Javier Mayor de Castro, James F Donaldson, Tim Muilwijk

BJU Int· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer.
Wojciech Krajewski, Júlia Aumatell, José Daniel Subiela, Łukasz Nowak, Andrzej Tukiendorf, Tim Muilwijk

Urol Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
Gautier Marcq, Beat Foerster, Mohammad Abufaraj, Surena F Matin, Mounsif Azizi, Tim Muilwijk

Eur Urol Focus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.
Tim Muilwijk, Murat Akand, Sofie Daelemans, Koen Marien, Yannick Waumans

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
Beat Foerster, Mohammad Abufaraj, Surena F Matin, Mounsif Azizi, Mohit Gupta, Tim Muilwijk

Eur Urol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non-muscle-invasive bladder cancer.
Tim Muilwijk, Murat Akand, Frank Van der Aa, Vincent De Coninck, Marc Claessens

J Cell Mol Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
Benjamin Pradere, David D'Andrea, Victor M Schuettfort, Beat Foerster, Fahad Quhal, Tim Muilwijk

World J Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.
Wojciech Krajewski, Marco Moschini, Joanna Chorbińska, Łukasz Nowak, Sławomir Poletajew, Tim Muilwijk

World J Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021.
Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, Ferran Algaba, Carsten Bokemeyer, Tim Muilwijk

Eur Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and harms of the new prostate cancer grade grouping on the prediction of long-term oncological outcomes in patients after radical prostatectomy.
Daimantas Milonas, Tim Muilwijk, Zilvinas Venclovas, Gaëtan Devos, Steven Joniau

Int J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients.
Thomas Gevaert, Yves-Rémi Van Eycke, Thomas Vanden Broeck, Hein Van Poppel, Isabelle Salmon, Tim Muilwijk

PLoS One· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold.
Zilvinas Venclovas, Tim Muilwijk, Aivaras J Matjosaitis, Mindaugas Jievaltas, Steven Joniau

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the oncological outcomes of three different bacillus Calmette-Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer.
Łukasz Nowak, Wojciech Krajewski, Marco Moschini, Joanna Chorbińska, Sławomir Poletajew, Tim Muilwijk

Arab J Urol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
Tim Muilwijk, Murat Akand, Francesco Soria, Andrea Giordano, Uros Milenkovic

BJU Int· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of postoperative complications of ileal conduits versus orthotopic neobladders.
Liesbeth Demaegd, Maarten Albersen, Tim Muilwijk, Uros Milenkovic, Lisa Moris

Transl Androl Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit.
Wojciech Krajewski, Marco Moschini, Łukasz Nowak, Sławomir Poletajew, Andrzej Tukiendorf, Tim Muilwijk

J Clin Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer.
David D'Andrea, Beat Foerster, Surena F Matin, Ja H Ku, Tim Muilwijk

Eur Urol Open Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to change the management of upper urinary tract urothelial carcinoma.
Murat Akand, Tim Muilwijk, Frank Van Der Aa, Steven Joniau

Cent European J Urol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasectomy of oligometastatic urothelial cancer: a single-center experience.
Tim Muilwijk, Murat Akand, Frank Van der Aa, Herlinde Dumez, Gert De Meerleer

Transl Androl Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis